Followers | 15 |
Posts | 889 |
Boards Moderated | 0 |
Alias Born | 04/28/2018 |
Tuesday, September 12, 2023 2:10:07 PM
Recent NVCR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 09:27:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:32:28 PM
- ノボキュア、2024年度第3四半期の決算を発表 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure meldet Finanzergebnisse des dritten Quartals 2024 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure présente ses résultats financiers pour le troisième trimestre 2024 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、クリストフ・ブラクマン氏を最高財務責任者(CFO)に任命 • Business Wire • 10/31/2024 11:07:00 AM
- Novocure nomme Christoph Brackmann au poste de directeur financier • Business Wire • 10/31/2024 11:07:00 AM
- Novocure ernennt Christoph Brackmann zum Finanzvorstand • Business Wire • 10/31/2024 03:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 11:02:07 AM
- Novocure Appoints Christoph Brackmann as Chief Financial Officer • Business Wire • 10/30/2024 11:02:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 11:00:29 AM
- Novocure Reports Third Quarter 2024 Financial Results • Business Wire • 10/30/2024 11:00:00 AM
- FDA genehmigt Optune Lua® von Novocure zur Behandlung des metastasierenden nicht-kleinzelligen Lungenkarzinoms • Business Wire • 10/22/2024 05:00:00 AM
- ノボキュアのOptune Lua®、転移性非小細胞肺がんの治療用としてFDAの承認を取得 • Business Wire • 10/20/2024 10:00:00 PM
- FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer • Business Wire • 10/15/2024 08:43:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:05:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 10:21:49 PM
- Novocure to Report Third Quarter 2024 Financial Results • Business Wire • 10/01/2024 11:00:00 AM
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy • Business Wire • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:00:17 AM
- Novocure Announces Planned CEO Transition • Business Wire • 09/03/2024 11:00:00 AM
- Novocure to Participate in 2024 Wells Fargo Healthcare Conference • Business Wire • 08/28/2024 11:00:00 AM
- Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer • Business Wire • 08/14/2024 11:00:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM